Literature DB >> 22859293

Regulator of G-protein signaling 3 isoform 1 (PDZ-RGS3) enhances canonical Wnt signaling and promotes epithelial mesenchymal transition.

Chong-Shan Shi1, Ning-Na Huang, John H Kehrl.   

Abstract

The Wnt β-catenin pathway controls numerous cellular processes including cell differentiation and cell-fate decisions. Wnt ligands engage Frizzled receptors and the low-density-lipoprotein-related protein 5/6 (LRP5/6) receptor complex leading to the recruitment of Dishevelled (Dvl) and Axin1 to the plasma membrane. Axin1 has a regulator of G-protein signaling (RGS) domain that binds adenomatous polyposis coli and Gα subunits, thereby providing a mechanism by which Gα subunits can affect β-catenin levels. Here we show that Wnt signaling enhances the expression of another RGS domain-containing protein, PDZ-RGS3. Reducing PDZ-RGS3 levels impaired Wnt3a-induced activation of the canonical pathway. PDZ-RGS3 bound GSK3β and decreased its catalytic activity toward β-catenin. PDZ-RGS3 overexpression enhanced Snail1 and led to morphological and biochemical changes reminiscent of epithelial mesenchymal transition (EMT). These results indicate that PDZ-RGS3 can enhance signals generated by the Wnt canonical pathway and that plays a pivotal role in EMT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859293      PMCID: PMC3460449          DOI: 10.1074/jbc.M112.361873

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  The Wnt signalling pathway.

Authors:  Joerg Huelsken; Juergen Behrens
Journal:  J Cell Sci       Date:  2002-11-01       Impact factor: 5.285

Review 2.  A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.

Authors:  Michael T Veeman; Jeffrey D Axelrod; Randall T Moon
Journal:  Dev Cell       Date:  2003-09       Impact factor: 12.270

3.  Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex.

Authors:  Vivian S W Li; Ser Sue Ng; Paul J Boersema; Teck Y Low; Wouter R Karthaus; Jan P Gerlach; Shabaz Mohammed; Albert J R Heck; Madelon M Maurice; Tokameh Mahmoudi; Hans Clevers
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

Review 4.  Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways.

Authors:  J R Miller; A M Hocking; J D Brown; R T Moon
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

5.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.

Authors:  Barbara Lustig; Boris Jerchow; Martin Sachs; Sigrid Weiler; Torsten Pietsch; Uwe Karsten; Marc van de Wetering; Hans Clevers; Peter M Schlag; Walter Birchmeier; Jürgen Behrens
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

7.  Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.

Authors:  D Yan; M Wiesmann; M Rohan; V Chan; A B Jefferson; L Guo; D Sakamoto; R H Caothien; J H Fuller; C Reinhard; P D Garcia; F M Randazzo; J Escobedo; W J Fantl; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 8.  Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins.

Authors:  J H Kehrl
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

9.  Additional 5' exons in the RGS3 locus generate multiple mRNA transcripts, one of which accounts for the origin of human PDZ-RGS3.

Authors:  John H Kehrl; Deepa Srikumar; Kathleen Harrison; Gaye L Wilson; Chong-Shan Shi
Journal:  Genomics       Date:  2002-06       Impact factor: 5.736

10.  Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition.

Authors:  Binhua P Zhou; Jiong Deng; Weiya Xia; Jihong Xu; Yan M Li; Mehmet Gunduz; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2004-09-26       Impact factor: 28.824

View more
  7 in total

1.  RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.

Authors:  Jesse W Williams; Douglas Yau; Nan Sethakorn; Jacob Kach; Eleanor B Reed; Tamson V Moore; Judy Cannon; Xiaohua Jin; Heming Xing; Anthony J Muslin; Anne I Sperling; Nickolai O Dulin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-27       Impact factor: 5.464

2.  Nuclear localizaiton of β-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer.

Authors:  Yanna Zhang; Bangzhong Liu; Qingyu Zhao; Teng Hou; Xin Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 3.  Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Authors:  Katherine E Squires; Carolina Montañez-Miranda; Rushika R Pandya; Matthew P Torres; John R Hepler
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 4.  The cellular story of dishevelleds.

Authors:  Anja Kafka; Sandra Bašić-Kinda; Nives Pećina-Šlaus
Journal:  Croat Med J       Date:  2014-10       Impact factor: 1.351

5.  MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xiaoying Li; Baosen Zhou
Journal:  Front Mol Biosci       Date:  2019-10-01

6.  Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin.

Authors:  Anja Kafka; Davor Tomas; Vili Beroš; Hrvoje Ivan Pećina; Martina Zeljko; Nives Pećina-Šlaus
Journal:  Int J Mol Sci       Date:  2014-06-13       Impact factor: 5.923

7.  Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.

Authors:  Piti Techavichit; Yang Gao; Lyazat Kurenbekova; Ryan Shuck; Lawrence A Donehower; Jason T Yustein
Journal:  BMC Cancer       Date:  2016-11-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.